employed before use. One milliliter of undiluted antiserum was injected intraperitoneally into normal 2-month-old C57BL/6 mice. The serum was recovered 2.5 hr later by cardiac puncture under ether anesthesis. The absorbed serum was examined for its specificity by both indirect immunofluorescence tests and immunoelectron microscopy with C57BL leukemia EL4(G-) to confirm that natural heteroantibody against mouse cells had been absorbed out, and, with EcG2, to show that antibodies against different classes of G antigens still remained. GSA sources. Blood from three groups of mice, (i) 5-to 8-month-old nonleukemic AKR, (ii) 5-to 8-month-old leukemic AKR, and (iii) 3-to 5-month-old nonleukemic C58, was collected with heparinized pipets from retro-orbital venous plexes. Plasma from 8 to 10 mice was pooled for each group. Pooled ascitic fluid of AKR mice bearing K36 leukemia was used as a fourth GSA source. These four GSA sources were used before and after removing Gross leukemia viruses by ultracentrifugation at 100,000 X g for 60 min.
Since they showed no difference with or without removal of Gross leukemia virus, the results will be described together. 
RESULTS
Indirect immunofluorescence method. Ascitic fluid of the AKR leukemia K36 and plasma of nonleukemic and leukemic AKR mice showed similar inhibiting effects on the reaction of Gtyping mouse and rat sera with viable E &lG2 cells (Tables 2 and 3 ). These GSA sources themselves completely inhibited the G-typing mouse serum. When the ascitic fluid or plasma was pretreated with the G-typing mouse or rat serum, they lost their inhibiting effects on the G-typing mouse serum. The results indicate that all classes of GSA in these sources which are capable of reacting with the G-typing mouse serum were completely eliminated by the pretreatment. The GSA sources also completely inhibited the G-typing rat serum. When they are pretreated with the Gtyping mouse serum, however, a partial inhibiting effect of these GSA sources on the G-typing rat serum remained, forming a plateau at the first several concentrations of the mixture (GSA sources and G-typing serum). The results suggest that the G-typing rat serum detected additional antigens in these GSA sources, which did not react with the G-typing mouse serum. C58 plasma showed different results from the other GSA sources mentioned above (Table 4 ). C58 plasma was only able partially to inhibit the G-typing mouse serum. When AKR plasma was added to C58 plasma, however, the mixture was able to inhibit completely the G-typing mouse serum, suggesting that C58 plasma lacks at least one specific GSA necessary to inhibit completely the G-typing mouse serum. On the other hand, the G-typing rat serum was absolutely inhibited by the C58 plasma. This was also substantiated by results obtained when C58 plasma was pretreated with the G-typing rat serum. All inhibiting effects on the G-typing rat serum were eliminated.
Serum of aged autoimmune NZB mice was also inhibited completely by the GSA sources used ( immunofluorescence tests are summarized in with the results obtained by the indirect immuno- Table 6 . fluorescence method. The G-typing mouse serum Immunoelectron microscopy. Immunoelectron recognized only GCSA (Fig. 2) , and this activity microscopy facilitates analysis of the detailed re-was completely inhibited with GSA sources from lationship among specificities of GSA, GCSA, AKR mice, K36 ascitic fluid, and plasma of both and VEA. nonleukemic and leukemic mice (Fig. 3) . GSA As summarized in Fig. 1 , these results correlate showing this inhibiting effect were eliminated by (Fig. 4) , indicating that the G-typing mouse serum recognized at least two different GSA. Pretreatment with either the G-typing mouse or rat serum completely eliminated the inhibiting effect of C58 plasma on the reaction of the G-typing mouse serum with GCSA. GSA sources from AKR or C58 mice completely inactivated the reactions of the G-typing rat serum with both GCSA and VEA (Fig. 5  versus 6 ), suggesting that these GSA sources contained GSA corresponding to all classes of GCSA and VEA detectable by the rat antiserum. Pretreatment of GSA sources with the G-typing mouse serum partially eliminated the reaction of the G-typing rat serum with GCSA, but did not prevent the inhibiting effects of the GSA corresponding to VEA (Fig. 7) . On the other hand, pretreatment with the G-typing rat serum eliminated all inhibiting effects of GSA sources, since positive reactions with GCSA and VEA were observed.
These results indicate that, although GSA sources from both AKR and C58 mice contain all classes of GSA recognized by the rat antiserum, at the dilution used, the mouse antiserum contains antibody(ies) against only some classes of GCSA.
As previously reported, NZB serum recognized only gsVEA of C-type viruses ( Fig. 8; references  1, 6, 7) . All GSA sources inhibited the activity of NZB serum with the envelope of Gross leukemia virus (Fig. 9) . Moreover, the G-typing rat serum recognized tsVEA of murine leukemia and myeloma viruses (T. Aoki, Bibl. Haematol., in press) and was inhibited by all GSA sources used in this study. Therefore, both GSA corresponding to gsVEA and tsVEA were detected in the body fluids. Pretreatment of GSA sources with the G-typing rat serum did not eliminate inhibiting effects on the NZB serum. In other words, specificities of anti-VEA antibodies in the G-typing rat serum and NZB serum were different.
DISCUSSION
The present study demonstrates several classes of GSA with different antigenic specificities. This type of analysis is essential for the future isolation of individual classes of GSA.
It has become evident that previously reported GSA detectable with the G-typing mouse serum C57BL/6 anti-K36 correspond to some classes of GCSA (6) . Inhibition tests of this typing serum with GSA sources from AKR mice and from C58 mice indicate that the G-typing mouse serum recognized at least two different specific GCSA: the previously described GCSAa (13) and another, which may be designated GCSAc. The C58 plasma contains only one GSA corresponding to one of these antigens, GCSAa, and both specificities exist in GSA sources of AKR mice; when AKR plasma was added to C58 plasma, the G-typing mouse serum was completely inhibited.
If the GCSAc specificity is absent from the GSA of C58 mice, why did GSA from both AKR and C58 mice have identical inhibiting effects on the G-typing rat serum? Two alternative explana- What is the relationship between GSA and G antigens on the surface of G+ cells and viruses? From where are these GSA derived? It is a reasonable possibility that G antigens on the surface may be released into the body fluids during turnover of the cell membrane (including virus budding). (31) . Finally, the presence of group-specific intraviral antigens (gsl, 3) in the various GSA sources used has been examined by both complement fixation and Ouchterlony methods. Since conclusive results were not obtained in the present study, however, their description is omitted in this paper. A large amount of purified gs antigens will be required for this solution.
